Physician profile
Paul A Conte
NPI 1669418166
$890.17
in general payments reported to CMS, 2019-2025
11 companies · $51.79 in 2025
The $51.79 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $490 · 2020: $126 · 2021: $63.90 · 2022: $28.98 · 2023: $95.09 · 2024: $34.04 · 2025: $51.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $180.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Portola Pharmaceuticals, LLC | $363.55 | 2019-2020 | |
| Allergan, INC. | $141.92 | 2019 | |
| Conmed Corporation | $78.13 | 2023 | Airseal |
| Davol INC. | $65.77 | 2019-2025 | Phasix Mesh |
| Covidien Lp | $59.90 | 2019 | |
| Medtronic, INC. | $44.24 | 2021 | |
| Braintree Laboratories, INC. | $42.58 | 2022-2024 | Suflave |
| Heron Therapeutics, INC. | $37.40 | 2022-2024 | Zynrelef |
| Novo Nordisk INC | $19.66 | 2021 | |
| Senseonics, Incorporated | $19.00 | 2020 | |
| Convatec INC. | $18.02 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Conte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.